SCOTTSDALE, Ariz. Oct. 21, 2008 TGen has spun off its third company: MedTrust Online, a reliable one-stop medical information source for oncologists.
The for-profit, privately held MedTrust Online draws on a variety of data sources, including genetic-based medical discoveries by the non-profit, Phoenix-based Translational Genomics Research Institute.
Scottsdale-based MedTrust Online aims to provide oncologists with the knowledge they need to design the best tailor-made treatments for individual patients.
"MedTrust Online is the first, comprehensive Internet-based solution that enables physicians to practice precision medicine,'' said Chris Yoo, MedTrust's President and Chief Executive Officer. "We provide clinically-useful knowledge to help physicians find and communicate with each other about cutting-edge cancer treatments for the benefit of their patients.''
MedTrust Online is the third company to spin out of TGen Accelerators Management, a firm designed to quickly translate TGen's genetic research discoveries into medical treatments and services.
"While MedTrust is our third spin-off company, it is a first in the informatics area for TGen Accelerators, and marks a beginning in the effort to use the vast knowledge generated by TGen scientists for the commercial benefit of doctors and the general public,'' said MaryAnn Guerra, TGen's Chief Business Officer and President of TGen Accelerators.
Richard Love, a former TGen Chief Operating Officer and former CEO of ILEX Oncology Inc, praised the advent of MedTrust as a boost to the local economy.
"The creation of MedTrust is part of the promise TGen holds for helping Arizona develop local biomedical expertise, jobs and productive venture partnerships,'' said Love, now a Manager for Translational Accelerator LLC, or TRAC, an Arizona-based bioscience venture capital group. "I personally believe that MedTrust can have a bigger positive impact on pati
|Contact: Russell J. Clark|
The Translational Genomics Research Institute